How is this announcement not price sensitive
- Forums
- ASX - By Stock
- CMB
- Ann: FDA Approves Cambium Bio's Potency Assay Strategy for Elate
CMB
cambium bio limited
Add to My Watchlist
13.2%
!
30.0¢

Ann: FDA Approves Cambium Bio's Potency Assay Strategy for Elate, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.035(13.2%) |
Mkt cap ! $5.484M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.5¢ | $12.80K | 43.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 56261 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 8085 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 56261 | 0.300 |
1 | 20000 | 0.280 |
1 | 25000 | 0.270 |
1 | 9883 | 0.260 |
2 | 20000 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 8085 | 2 |
0.330 | 529 | 1 |
0.390 | 6535 | 1 |
0.395 | 650 | 1 |
0.400 | 1000 | 1 |
Last trade - 10.45am 28/07/2025 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online